[Thrombolytic therapy with ultra-high doses of streptokinase].
Two pilot studies were carried out in patients suffering from acute myocardial infarction. They received high doses of streptokinase and acylated streptokinase-plasminogen activator complex intravenously as a bolus injection. Furthermore, the possibility of using streptokinase bolus therapy was examined in patients with acute vascular occlusion. Due to the limited number and the heterogenicity of cases the results obtained in patients with acute myocardial infarction are to evaluate with some reservation. In patients with acute vascular occlusion streptokinase bolus therapy at high doses proved to be a promising alternative to the conventional therapy.
D017023:Coronary Angiography; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005342:Fibrinolysis; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D013300:Streptokinase; D010960:Plasminogen Activators
Thrombolytische Therapie mit ultrahohen Streptokinasedosen.